Patents by Inventor Bjarke Mirner Klein

Bjarke Mirner Klein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963995
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: April 23, 2024
    Assignee: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20240024424
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.
    Type: Application
    Filed: July 25, 2023
    Publication date: January 25, 2024
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN
  • Patent number: 11744879
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: September 5, 2023
    Assignee: FERRING B.V.
    Inventors: Joan-Carles Arce Saez, Lisbeth Helmgaard, Bjarke Mirner Klein
  • Publication number: 20230139407
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
    Type: Application
    Filed: August 3, 2022
    Publication date: May 4, 2023
    Applicant: Ferring B.V.
    Inventors: JOAN CARLES ARCE SAEZ, LISBETH HELMGAARD, BJARKE MIRNER KLEIN
  • Patent number: 11439686
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: September 13, 2022
    Assignee: FERRING B.V.
    Inventors: Joan Carles Arce Saez, Lisbeth Helmgaard, Bjarke Mirner Klein
  • Publication number: 20220118046
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: May 27, 2021
    Publication date: April 21, 2022
    Applicant: Ferring B.V.
    Inventors: Bjarke Mirner KLEIN, Jens Peter NORGAARD
  • Publication number: 20210353717
    Abstract: Methods using and compositions including FSH for use in the treatment of infertility are described, wherein the dose is selected based on the patient's age to optimise cumulative efficiency and/or reduce OHSS risk.
    Type: Application
    Filed: October 17, 2019
    Publication date: November 18, 2021
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN, Patrick HEISER
  • Patent number: 11020448
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: June 1, 2021
    Assignee: FERRING B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20200353053
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 12, 2020
    Applicant: FERRING B.V.
    Inventors: Joan Carles ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN
  • Publication number: 20200197493
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.
    Type: Application
    Filed: August 31, 2018
    Publication date: June 25, 2020
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN
  • Patent number: 10660938
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 26, 2020
    Assignee: FERRING B.V.
    Inventors: Joan Carles Arce Saez, Lisbeth Helmgaard, Bjarke Mirner Klein
  • Publication number: 20190134146
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: October 17, 2018
    Publication date: May 9, 2019
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Patent number: 10137167
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: November 27, 2018
    Assignee: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20180125942
    Abstract: Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
    Type: Application
    Filed: April 15, 2016
    Publication date: May 10, 2018
    Applicant: FERRING B.V.
    Inventors: Joan Carlos ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN
  • Publication number: 20140113863
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: December 30, 2013
    Publication date: April 24, 2014
    Applicant: Ferring B.V.
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard
  • Publication number: 20100286045
    Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
    Type: Application
    Filed: March 25, 2010
    Publication date: November 11, 2010
    Inventors: Bjarke Mirner Klein, Jens Peter Norgaard